You cannot currently buy generic Dymista (azelastine/fluticasone nasal spray), as there is a patent that prevents any generic versions from being made in the United States. This may change, however, after the first patent expires in August 2023, unless new patents or lawsuits are filed. Although azelastine and fluticasone are considered "generic names" for Dymista, they are not actually generic versions of it.
Dymista™ (azelastine/fluticasone nasal spray) is a prescription nasal spray used to treat nasal allergies (known medically as allergic rhinitis). It contains two different active ingredients:
- Fluticasone -- a corticosteroid, or simply "steroid" for short
- Azelastine -- an antihistamine.
Dymista is manufactured by Meda Pharmaceuticals, Inc. It is currently under the protection of a patent that prevents any generic Dymista from being manufactured in the United States
The first patent for Dymista is set to expire in August 2023. This is the earliest predictable date that a generic version could become available.
However, other circumstances could come up to delay or shorten the exclusivity period. This could include such things as lawsuits or patents for new Dymista uses. Once the patent expires, there may be several companies that manufacture a generic Dymista drug.
No -- azelastine and fluticasone are the active ingredients in Dymista. They are also available separately in several other medications, including a few different nasal sprays. These are not generic versions of Dymista but are different products altogether. What can be confusing is that the active ingredient of a drug is often referred to as the "generic name."
The generic name is different from a generic version of a medicine. In order for there to be a generic version, the original medicine must have gone off-patent and another company besides the original manufacturer must make the product.